Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Other |
Change in systolic blood pressure |
Change in resting systolic blood pressure (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in diastolic blood pressure |
Change in resting diastolic blood pressure (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in BMI |
Body mass index (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in Weight |
Change in body weight (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in waist circumference |
Change in waist circumference (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Compliance: Number of lids and Unused Containers |
Number of lids and unused containers of intervention foods (control vs. yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Dietary records |
Comparison of dietary records (control vs. yogurt) |
2 Weeks Prior to Intervention, Weeks 0-4, Weeks 4-8, Weeks 8-12 |
|
Other |
Change in gut microbiota diversity |
Change in gut microbiota beta diversity (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal water ex vivo barrier disrupting activity |
Change in barrier disrupting activity of fecal water applied to cultured Caco-2 cells (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal total organic carbon |
Change in total organic carbon (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal butyrate |
Change in fecal butyrate (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal propionate |
Change in fecal propionate (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal acetate |
Change in fecal acetate (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal bile acid (deoxycholic acid) |
Change in fecal deoxycholic acid (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal bile acid (lithocholic acid) |
Change in fecal lithocholic acid (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal bile acid (hyodeoxycholic acid) |
Change in fecal hyodeoxycholic acid (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Other |
Change in fecal bile acid (3ß,12a-Dihydroxy-5ß-cholan-24-oic acid) |
Change in fecal 3ß,12a-Dihydroxy-5ß-cholan-24-oic acid (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Primary |
Change in Th17 proportion |
Change in proportions of circulating Th17 cells (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Treg proportion |
Change in proportion of circulating Treg cells (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Treg subpopulation |
Change in proportion of circulating Treg subpopulation (FoxP3+ IL-10+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Th17 subpopulation (IL-17A+ TNFa+) |
Change in proportion of circulating Th17 subpopulation (IL-17A+ TNFa+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Th17 subpopulation (IL-17A+ IFNd+) |
Change in proportion of circulating Th17 subpopulation (IL-17A+ IFNd+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Th17 subpopulation (IL-17A+ IL-22+) |
Change in proportion of circulating Th17 subpopulation (IL-17A+ IL-22+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Th17 subpopulation (IL-17A+ FoxP3+) |
Change in proportion of circulating Th17 subpopulation (IL-17A+ FoxP3+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Th17 subpopulation (IL-17A+ IL-10+) |
Change in proportion of circulating Th17 subpopulation (IL-17A+ IL-10+) (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma tumor necrosis factor alpha (TNF-alpha) |
Change in fasting plasma TNF-alpha (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interferon gamma (IFN-gamma) |
Change in fasting plasma IFN-gamma (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interleukin-6 (IL-6) |
Change in fasting plasma IL-6 (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interleukin-17A (IL-17A) |
Change in fasting plasma IL-17A (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interleukin-4 |
Change in fasting plasma IL-4 (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interleukin-22 (IL-22) |
Change in fasting plasma IL-22 (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma interleukin-10 (IL-10) |
Change in fasting plasma IL-10 (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in plasma transforming growth factor beta (TGF-beta) |
Change in fasting plasma TGF-beta (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in retinoic acid receptor-related orphan nuclear receptor gamma T (RORgammaT) expression |
Change in fasting plasma RORgammaT expression (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in Forkhead box P3 (FoxP3) expression |
Change in fasting FoxP3 expression (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal calprotectin |
Change in fecal calprotectin (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal tumor necrosis factor alpha (TNF-alpha) |
Change in fecal TNF-alpha (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal interleukin 1 alpha (IL-1alpha) |
Change in fecal IL-1alpha (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal interleukin 1beta (IL-1beta) |
Change in fecal IL-1beta (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal interleukin-6 (IL-6) |
Change in fecal IL-6 (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|
Secondary |
Change in fecal interleukin-17A (IL-17A) |
Change in fecal IL-17A (change in control vs. change in yogurt) |
Baseline, Week 4, Week 8, Week 12 |
|